Low dose lithium treatment of behavioral complications in Alzheimer's disease: Lit-AD randomized clinical trial

The most common type of dementia, Alzheimer's disease (AD), is characterized by progressive cognitive and functional decline. Nearly all patients with Alzheimer's disease (AD) develop neuropsychiatric symptoms, which include psychosis, agitation, depression, anxiety, and insomnia.1 Agitation, which can include aggressive behavior,2 occurs in one-third of community-dwelling patients with AD and is more common in nursing homes.1,3 Delusions and hallucinations occur in 15-30% and 5-15% of patients with AD, respectively.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: Regular Research Article Source Type: research